Cresset Asset Management’s Boston Scientific BSX Stock Holding History

Cresset Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.42M	Buy	56,634 +32,300	+133%	+$1.75M	0.01%	615
2026 Q1	$1.53M	Buy	24,334 +7,206	+42%	+$576K	0.01%	633
2025 Q4	$1.63M	Buy	17,128 +722	+4%	+$70.8K	0.01%	625
2025 Q3	$1.6M	Buy	16,406 +3,839	+31%	+$398K	0.01%	610
2025 Q2	$1.35M	Sell	12,567 -1,324	-10%	-$134K	0.01%	605
2025 Q1	$1.4M	Sell	13,891 -1,559	-10%	-$157K	0.01%	654
2024 Q4	$1.38M	Sell	15,450 -88,821	-85%	-$7.82M	0.01%	677
2024 Q3	$8.74M	Buy	104,271 +4,309	+4%	+$340K	0.03%	343
2024 Q2	$7.7M	Buy	99,962 +12,543	+14%	+$918K	0.03%	343
2024 Q1	$5.99M	Buy	87,419 +11,419	+15%	+$734K	0.03%	353
2023 Q4	$4.39M	Buy	76,000 +4,722	+7%	+$252K	0.03%	375
2023 Q3	$3.76M	Buy	71,278 +7,389	+12%	+$388K	0.01%	388
2023 Q2	$3.46M	Buy	63,889 +41,994	+192%	+$2.19M	﹤0.01%	498
2023 Q1	$1.1M	Buy	21,895 +504	+2%	+$23.8K	0.02%	330
2022 Q4	$937K	Buy	+21,391	New	+$926K	0.01%	312
2022 Q2	–	Sell	-11,317	Closed	-$501K	–	962
2022 Q1	$501K	Buy	11,317 +2,268	+25%	+$98.3K	0.01%	607
2021 Q4	$385K	Buy	9,049 +1,345	+17%	+$56.5K	﹤0.01%	788
2021 Q3	$335K	Buy	7,704 +1,397	+22%	+$61.8K	﹤0.01%	797
2021 Q2	$270K	Sell	6,307 -3,781	-37%	-$159K	﹤0.01%	827
2021 Q1	$390K	Buy	+10,088	New	+$382K	0.01%	559
2020 Q4	–	Sell	-5,544	Closed	-$212K	–	777
2020 Q3	$212K	Sell	5,544 -3,813	-41%	-$147K	﹤0.01%	627
2020 Q2	$329K	Buy	9,357 +1,731	+23%	+$62.3K	0.01%	432
2020 Q1	$249K	Buy	7,626 +96	+1%	+$3.75K	0.01%	450
2019 Q4	$341K	Buy	7,530 +844	+13%	+$35.3K	0.01%	384
2019 Q3	$272K	Buy	+6,686	New	+$283K	0.01%	413
2019 Q2	–	Sell	-3,508	Closed	-$135K	–	643
2019 Q1	$135K	Sell	3,508 -333	-9%	-$12.7K	0.01%	471
2018 Q4	$136K	Buy	+3,841	New	+$139K	0.01%	268

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Cresset Asset Management's BSX Position: Q2 2026 in Review

Cresset Asset Management increased its Boston Scientific (BSX) stake by 133% in Q2 2026, buying an estimated $1.75M and bringing the position to 56,634 shares worth $2.42M. The position accounts for 0.01% of the portfolio, ranked #615.

Cresset Asset Management first reported a position in BSX in Q4 2018 and has held it in 27 quarters since. The position peaked at $8.74M in Q3 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Cresset Asset Management held 56,634 shares of Boston Scientific worth $2.42M as of Q2 2026.
Cresset Asset Management bought 32,300 Boston Scientific shares in Q2 2026, an estimated $1.75M.
Boston Scientific made up 0.01% of Cresset Asset Management's portfolio in Q2 2026, its #615 holding.
Cresset Asset Management first reported a position in Boston Scientific in Q4 2018 and has held it in 27 quarters since.
Cresset Asset Management's Boston Scientific position peaked at $8.74M in Q3 2024.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.